Press release
North America and Europe Sterile Injectables CMO Market Set to Record US$ 22.37 Billion by 2033., Growth by Poised to Surge - Recipharm AB, Jubilant HollisterStier, Grand River Aseptic Manufacturing, and Afton Scientific
North America and Europe Sterile Injectables CMO Market Size 2026
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/north-america-and-europe-sterile-injectables-cmo-market?kb
North America: Recent Industry Developments - Sterile Injectables CMO
✅ March 2026: Lonza (U.S. operations) expanded aseptic fill-finish capacity to support growing demand for biologics and high-potency injectable therapies.
✅ February 2026: Thermo Fisher Scientific (Patheon) enhanced sterile injectable manufacturing capabilities with new high-speed vial filling lines in North America.
✅ January 2026: Catalent Inc. increased investment in prefilled syringe and lyophilization capacity to strengthen biologics and vaccine production support.
✅ December 2025: Baxter BioPharma Solutions upgraded its sterile manufacturing facilities to improve large-scale injectable drug production efficiency and compliance standards.
Designed for industry leaders and partners, this report offers actionable insights for strategic growth: https://www.datamintelligence.com/partner-identification-enquiry/north-america-and-europe-sterile-injectables-cmo-market?kb
List of Top Key Players 2026:
Catalent, Inc, Lonza, Vetter Pharma, Thermo Fisher Scientific Inc., Recipharm AB, Jubilant HollisterStier, Grand River Aseptic Manufacturing, and Afton Scientific
Growth Forecast Projected 2026-2033:
The North America and Europe Sterile Injectables CMO Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Industry Developments 2025-2026:
✅ April 2026: Leading CDMOs in North America expanded high-potency and aseptic fill-finish capacities to support rising demand for biologics, oncology injectables, and mRNA-based therapies.
✅ February 2026: European manufacturers strengthened investments in advanced isolator-based sterile manufacturing lines to enhance contamination control and meet EU GMP Annex 1 compliance standards.
✅ January 2026: North American CMOs increased partnerships with pharmaceutical companies to secure long-term capacity agreements for prefilled syringes and lyophilized injectable products.
✅ December 2025: European CDMOs accelerated expansion of single-use system technologies to improve production flexibility and reduce cross-contamination risks in sterile environments.
✅ November 2025: U.S.-based contract manufacturers expanded automation and digital quality systems to improve batch traceability, real-time monitoring, and regulatory compliance efficiency.
✅ October 2025: Growing outsourcing demand from pharma and biotech firms led CMOs in both regions to scale up sterile fill-finish infrastructure to address global injectable supply shortages.
How Our Market Research Process Works:
The North America and Europe Sterile Injectables CMO Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the North America and Europe Sterile Injectables CMO ecosystem.
Latest Mergers & Acquisitions (M & A) 2025-2026:
• North America: THL Partners agreed to acquire Celerion (US/EU pharma services supporting sterile injectables & clinical development) for ~US$1.8B, strengthening sterile injectable and bioanalytical CDMO capacity (Apr 2026)
• North America: Siegfried completed acquisition of three drug substance/CDMO sterile & injectable manufacturing sites in the US (Delaware, Georgia) as part of global expansion into high-value pharma manufacturing (Apr 2026 closing)
• North America: PAI Pharma acquired Nivagen Pharmaceuticals (US sterile injectables producer) to expand domestic IV bags, vials, and prefilled syringe manufacturing amid ongoing drug shortages (Jan 2026)
• North America: CDMO consolidation trend accelerated with continued PE-backed exits targeting sterile injectables specialization and reshoring capacity expansion across US facilities (Jan-Apr 2026)
• Europe: Siegfried's broader acquisition strategy included integration of global sterile injectable and drug substance manufacturing assets across EU-linked supply networks, reinforcing cross-Atlantic CDMO consolidation (Apr 2026 closing)
• Europe: Celerion expansion strategy and PE acquisition activity highlighted Europe-North America integrated clinical + sterile injectable outsourcing platforms gaining M&A interest (Apr 2026)
• Europe: 2026 CDMO deal environment remained driven by specialization in sterile injectables, radiopharma, and complex biologics manufacturing across European pharma supply chains (Jan-Apr 2026)
Unlock & Get Full 360° Best Strategic Market Report: https://www.datamintelligence.com/buy-now-page?report=north-america-and-europe-sterile-injectables-cmo-market?kb
Europe: Recent Industry Developments - Sterile Injectables CMO
✅ March 2026: Vetter Pharma expanded its aseptic fill-finish operations in Germany to meet rising global demand for complex injectable formulations.
✅ February 2026: Recipharm AB enhanced sterile manufacturing capabilities across European sites, focusing on biologics and high-value injectable drugs.
✅ January 2026: Fareva strengthened its injectable production network in France with new automated sterile filling systems and capacity expansion.
✅ December 2025: Fresenius Kabi increased investment in European sterile injectables manufacturing infrastructure to support oncology and critical care therapies.
Major Focused Key Segmentation (2026):
By Product Type: Small Molecules and Large Molecules
By Dosage Form: Liquid Injectables, Pre-filled Syringes, Lyophilized Injectables, and Others
By Therapeutic Area: Oncology, Cardiology, Neurology, Pain Management, Endocrinology, Autoimmune Diseases, and Others
Regional Growth Analysis for Market (2026):
⇥ North America is expected to dominate the North America and Europe sterile injectables CMO market with a 59.51% in 2024
⇥ US & Germany for aseptic injectable filling, while Catalent has invested over $350 million in recent sterile fill-finish expansions across the U.S. and Europe
Get Report for Strategic Market Growth Customization: https://datamintelligence.com/customize/north-america-and-europe-sterile-injectables-cmo-market?kb
FAQ
Q1: What is the present market size and value of the North America and Europe Sterile Injectables CMO Market?
A: The North America and Europe Sterile Injectables CMO Market was valued at US$ 9.83 Billion in 2024 and is projected to reach US$ 22.37 Billion by 2033, growing steadily over the forecast period.
Q2: How fast is the market expected to grow?
A: The North America and Europe Sterile Injectables CMO market is expected to register a strong CAGR of 9.8% during the 2025-2033
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America and Europe Sterile Injectables CMO Market Set to Record US$ 22.37 Billion by 2033., Growth by Poised to Surge - Recipharm AB, Jubilant HollisterStier, Grand River Aseptic Manufacturing, and Afton Scientific here
News-ID: 4503597 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
IoT and Virtual Hospital Market Set to Reach USD 116.66 Billion by 2033 | North …
The global IoT and virtual hospital market was valued at USD 26.46 billion in 2025 and is projected to reach USD 116.66 billion by 2033, growing at a CAGR of 18.6% during the forecast period from 2026 to 2033. The market is experiencing rapid expansion driven by the increasing demand for remote healthcare delivery, rising adoption of connected medical devices, and the growing need for efficient, patient-centric care models. IoT-enabled…
Dark Fiber Network Market Set to Record US$ 13.29 billion by 2033., Growth by su …
Dark Fiber Network Market reached US$ 5.32 billion in 2025 and is expected to reach US$ 13.29 billion by 2033, growing with a CAGR of 12.29% during the forecast period 2026-2033.
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/dark-fiber-network-market?kb
United States: Recent Industry Developments
✅ March 2026: Lumen Technologies expanded its national dark fiber backbone across key data center corridors to support hyperscale cloud and AI workloads.
✅ February 2026:…
Telemedicine Market to Reach USD 488.89 Billion by 2033, Led by North America wi …
The global telemedicine market reached USD 151.49 billion in 2025 and is projected to reach USD 488.89 billion by 2033, growing at a CAGR of 16.8% during the forecast period from 2026 to 2033. The market is experiencing rapid expansion driven by the increasing demand for remote healthcare services, rising prevalence of chronic diseases, and growing need for accessible and cost-effective care solutions. Telemedicine is enabling virtual consultations, remote diagnostics,…
Home Healthcare Devices Market to Reach USD 82.27 Billion by 2033, Led by North …
The global home healthcare devices market was valued at USD 49.40 billion in 2025 and is projected to reach USD 82.27 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of chronic diseases, rising aging population, and growing demand for cost-effective home-based care solutions. Patients and healthcare providers are increasingly shifting…
More Releases for Europe
2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends
Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging…
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business.
A new report as a Digital Strategy Consulting market that includes a comprehensive analysis…
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• McKinsey
• The Boston Consulting Group
• Bain & Company
• Booz & Co.
• Roland Berger Europe
• Oliver Wyman Europe
• A.T. Kearney Europe
• Deloitte
• Accenture Europe
Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB
Market segment by Type, the product can be split into
• Operations Consultants
• Business Strategy Consultants
• Investment Consultants
• Sales and…
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage.
The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China.
In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
